← Back to Search

Observational (neuropsychological and behavioral tests) for Childhood Cancer

N/A
Waitlist Available
Led By Leanne M Embry
Research Sponsored by Children's Oncology Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This research trial studies neuropsychological (learning, remembering or thinking) and behavioral outcomes in children and adolescents with cancer by collecting information over time from a series of tests.

Eligible Conditions
  • Childhood Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Observational (neuropsychological and behavioral tests)Experimental Treatment2 Interventions
Parent and child participants complete the COG Standard Neuropsychological and Behavioral Battery at approximately 9, 30, and 60 months post-diagnosis in a 1-2 hour testing session conducted by a neuropsychologist or psychologist. The Battery consists of measures of intelligence, processing speed, attention, memory, language preference, behavioral/social/emotional function, executive function, adaptive function, and quality of life.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Assessment
2011
Completed Phase 2
~1420

Find a Location

Who is running the clinical trial?

Children's Oncology GroupLead Sponsor
460 Previous Clinical Trials
238,837 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,914 Previous Clinical Trials
41,011,484 Total Patients Enrolled
Leanne M EmbryPrincipal InvestigatorChildren's Oncology Group
~72 spots leftby Nov 2025